| 51 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|
| 52 |
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al |
1:22-cv-00971 |
D.Del. |
|
|
|
|
| 53 |
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al |
1:22-cv-00971 |
D.Del. |
|
|
|
|
| 54 |
BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al |
3:22-cv-02345 |
D.N.J. |
|
|
|
|
| 55 |
BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al |
3:22-cv-02345 |
D.N.J. |
|
|
|
|
| 56 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
| 57 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
| 58 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
| 59 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
| 60 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
| 61 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
| 62 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
| 63 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 64 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 65 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 66 |
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al |
1:18-cv-01673 |
D.Del. |
|
|
|
|
| 67 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
| 68 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
| 69 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
| 70 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
| 71 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:17-cv-03387 |
D.N.J. |
|
|
|
|
| 72 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 73 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 74 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 75 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 76 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 77 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 78 |
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al. |
1:16-cv-01299 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 79 |
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al. |
1:16-cv-01299 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 80 |
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al. |
1:16-cv-01299 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 81 |
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al. |
1:16-cv-01299 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 82 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
| 83 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
| 84 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
| 85 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
| 86 |
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al |
1:16-cv-04414 |
D.N.J. |
|
|
|
|
| 87 |
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al |
1:16-cv-04414 |
D.N.J. |
|
|
|
|
| 88 |
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al |
1:16-cv-04414 |
D.N.J. |
|
|
|
|
| 89 |
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al |
1:16-cv-04414 |
D.N.J. |
|
|
|
|
| 90 |
AUROBINDO PHARMA USA INC. et al v. APICORE US LLC et al |
1:16-cv-03358 |
D.N.J. |
|
|
|
|
| 91 |
AUROBINDO PHARMA USA INC. et al v. APICORE US LLC et al |
1:16-cv-03358 |
D.N.J. |
|
|
|
|
| 92 |
Mylan Institutional LLC et al v. Aurobindo Pharma Ltd et al |
2:16-cv-00491 |
E.D.Tex. |
|
|
|
|
| 93 |
Mylan Institutional LLC et al v. Aurobindo Pharma Ltd et al |
2:16-cv-00491 |
E.D.Tex. |
|
|
|
|
| 94 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al |
3:15-cv-05982 |
D.N.J. |
|
|
|
- MSN Laboratories Private Limited
- Sun Pharma Global FZE
- Huahai US Inc.
- Zydus Pharmaceuticals (USA) Inc.
- 1149336 Ontario Inc.
- Aurobindo Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddys Laboratories, Ltd.
- Dr. Reddys Laboratories, Inc.
- InvaGen Pharmaceuticals Inc.
- Solco Healthcare US, LLC
- Mylan, Inc.
- Aurobindo Pharma Ltd.
- HEC Pharm Group
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Mylan Laboratories Limited
- Prinston Pharmaceutical Inc.
- Trustees of Tufts College
- Intas Pharmaceuticals Limited
- Accord Healthcare, Inc.
- HEC Pharm Group
- ASSIA CHEMICAL INDUSTRIES LTD.
- Sun Pharmaceutical Industries, Inc.
- HEC Pharm Group
- Teva Pharmaceuticals USA, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cadila Healthcare Ltd.
- Tufts Medical Center
- PHV JASON Z. PESICK
- Mylan Pharmaceuticals, Inc.
- MSN Pharmaceuticals, Inc.
|
| 95 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al |
3:15-cv-05982 |
D.N.J. |
|
|
|
- MSN Laboratories Private Limited
- Sun Pharma Global FZE
- Huahai US Inc.
- Zydus Pharmaceuticals (USA) Inc.
- 1149336 Ontario Inc.
- Aurobindo Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddys Laboratories, Ltd.
- Dr. Reddys Laboratories, Inc.
- InvaGen Pharmaceuticals Inc.
- Solco Healthcare US, LLC
- Mylan, Inc.
- Aurobindo Pharma Ltd.
- HEC Pharm Group
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Mylan Laboratories Limited
- Prinston Pharmaceutical Inc.
- Trustees of Tufts College
- Intas Pharmaceuticals Limited
- Accord Healthcare, Inc.
- HEC Pharm Group
- ASSIA CHEMICAL INDUSTRIES LTD.
- Sun Pharmaceutical Industries, Inc.
- HEC Pharm Group
- Teva Pharmaceuticals USA, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cadila Healthcare Ltd.
- Tufts Medical Center
- PHV JASON Z. PESICK
- Mylan Pharmaceuticals, Inc.
- MSN Pharmaceuticals, Inc.
|
| 96 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al |
3:15-cv-05982 |
D.N.J. |
|
|
|
- MSN Laboratories Private Limited
- Sun Pharma Global FZE
- Huahai US Inc.
- Zydus Pharmaceuticals (USA) Inc.
- 1149336 Ontario Inc.
- Aurobindo Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddys Laboratories, Ltd.
- Dr. Reddys Laboratories, Inc.
- InvaGen Pharmaceuticals Inc.
- Solco Healthcare US, LLC
- Mylan, Inc.
- Aurobindo Pharma Ltd.
- HEC Pharm Group
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Mylan Laboratories Limited
- Prinston Pharmaceutical Inc.
- Trustees of Tufts College
- Intas Pharmaceuticals Limited
- Accord Healthcare, Inc.
- HEC Pharm Group
- ASSIA CHEMICAL INDUSTRIES LTD.
- Sun Pharmaceutical Industries, Inc.
- HEC Pharm Group
- Teva Pharmaceuticals USA, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cadila Healthcare Ltd.
- Tufts Medical Center
- PHV JASON Z. PESICK
- Mylan Pharmaceuticals, Inc.
- MSN Pharmaceuticals, Inc.
|
| 97 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al |
3:15-cv-05982 |
D.N.J. |
|
|
|
- MSN Laboratories Private Limited
- Sun Pharma Global FZE
- Huahai US Inc.
- Zydus Pharmaceuticals (USA) Inc.
- 1149336 Ontario Inc.
- Aurobindo Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddys Laboratories, Ltd.
- Dr. Reddys Laboratories, Inc.
- InvaGen Pharmaceuticals Inc.
- Solco Healthcare US, LLC
- Mylan, Inc.
- Aurobindo Pharma Ltd.
- HEC Pharm Group
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Mylan Laboratories Limited
- Prinston Pharmaceutical Inc.
- Trustees of Tufts College
- Intas Pharmaceuticals Limited
- Accord Healthcare, Inc.
- HEC Pharm Group
- ASSIA CHEMICAL INDUSTRIES LTD.
- Sun Pharmaceutical Industries, Inc.
- HEC Pharm Group
- Teva Pharmaceuticals USA, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cadila Healthcare Ltd.
- Tufts Medical Center
- PHV JASON Z. PESICK
- Mylan Pharmaceuticals, Inc.
- MSN Pharmaceuticals, Inc.
|
| 98 |
AstraZeneca AB v. Aurobindo Pharma Ltd. et al |
1:14-cv-01469 |
D.Del. |
|
|
|
|
| 99 |
Alcon Pharmaceuticals Ltd et al v. Aurobindo Pharma Ltd. et al |
1:14-cv-00930 |
D.Del. |
|
|
|
|
| 100 |
Alcon Pharmaceuticals Ltd et al v. Aurobindo Pharma Ltd. et al |
1:14-cv-00930 |
D.Del. |
|
|
|
|